Teriparatide [human parathyroid hormone (1-34)] therapy in men with osteoporosis

被引：0
|
作者：
Kaufman, J. -M. [1 ]
机构：
[1] Ghent Univ Hosp, Unit Osteoporosis & Metab Bone Dis, Dept Endocrinol, Ghent, Belgium
来源：
OSTEOPOROSIS INTERNATIONAL | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S184 / S185
页数：2
相关论文
共 50 条
  • [1] The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis
    Orwoll, E
    Scheele, W
    Paul, S
    Adami, S
    Syversen, U
    Diez-Perez, A
    Kaufman, JM
    Clancy, A
    Gaich, G
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (01) : 9 - 17
  • [2] The importance of bisphosphonate therapy mass in men after therapy with teriparatide [human parathyroid hormone(1-34)]
    Kurland, ES
    Heller, SL
    Diamond, B
    McMahon, DJ
    Cosman, F
    Bilezikian, JP
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 (12) : 992 - 997
  • [3] Teriparatide (biosynthetic human parathyroid hormone 1-34): A new paradigm in the treatment of osteoporosis
    Brixen, KT
    Christensen, PM
    Ejersted, C
    Langdahl, BL
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2004, 94 (06) : 260 - 270
  • [4] Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review
    Moca Trevisani, Virginia Fernandes
    Riera, Rachel
    Imoto, Aline Mizusaki
    Saconato, Humberto
    Atallah, Alvaro Nagib
    [J]. SAO PAULO MEDICAL JOURNAL, 2008, 126 (05): : 279 - 284
  • [5] Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis
    Zanchetta, JR
    Bogado, CE
    Ferretti, JL
    Wang, O
    Wilson, MG
    Sato, M
    Gaich, GA
    Dalsky, GP
    Myers, SL
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (03) : 539 - 543
  • [6] Teriparatide (hPTH-[1-34]) - A recombinant human parathyroid hormone fragment with anabolic actions for the treatment of osteoporosis
    Ashworth, LE
    [J]. FORMULARY, 2002, 37 (03) : 129 - +
  • [7] Teriparatide -: rhPTH(1-34) -: LY-333334 -: Forteo® -: Treatment of osteoporosis -: Parathyroid hormone
    不详
    [J]. DRUGS OF THE FUTURE, 2001, 26 (08) : 824 - 827
  • [8] A novel human parathyroid hormone (1-34) analog for the treatment of osteoporosis
    Feng, Jiao
    Liu, Yanhua
    Xing, Yun
    Wang, Huaqian
    Li, Taiming
    Liu, Jingjing
    Fan, Hao
    Cao, Rongyue
    [J]. PEPTIDES, 2009, 30 (06) : 1173 - 1180
  • [9] Prescription pattern of human recombinant 1-34 parathyroid hormone (teriparatide, forsteo®) in Sweden
    Ljunggren, O.
    Toll, A.
    Myren, K.-J.
    Mullarney, T.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S71 - S72
  • [10] Intranasal delivery of recombinant human parathyroid hormone [hPTH (1-34)], teriparatide in rats
    Agu, RU
    Valiveti, S
    Earles, DC
    Klausner, M
    Hayden, PJ
    Wermeling, DP
    Stinchcomb, AL
    [J]. ENDOCRINE RESEARCH, 2004, 30 (03) : 455 - 467
12345